Regen BioPharma Inc (RGBP)

[Schuller]

Been here a long time and have had many conversations with Koos over the years. Sold a lot of shares on the first run up but got back in here heavy, Koos is excited about something.

This quick meeting of the Onco Pharma board mid November is also interesting. That company seems really aggressive in their growth. They may have seen something they like in the material they've licensed from Regen.

Regen hires a company to assess their assets also mid-Nov.

It now seems clear that humanity will be living with covid, variants and possibly new viruses into the future and too many companies are trying to catch up with mRNA. There's a full library attached to Regen.

Either way, no brainer at this price.

My Opinion
Schuller